The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes

Pediatric Diabetes

Volumn 16, Issue 1, 2015, Pages 1-9

  Karaa, Amel ^a   Goldstein, Amy ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Diabetes; Kearns Sayre syndrome; MELAS; Mitochondria; mtDNA

Indexed keywords

CELL NUCLEUS DNA; MITOCHONDRIAL DNA; TRANSFER RNA; LEUCINE TRANSFER RNA;

ADULTHOOD; ALPERS DISEASE; ATAXIA; BRAIN DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; COLOR VISION DEFECT; CONSTIPATION; COPY NUMBER VARIATION; DEMENTIA; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; DIABETIC PATIENT; DIFFERENTIAL DIAGNOSIS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DYSARTHRIA; ENDOCRINE DISEASE; ENDOCRINOLOGIST; EXTERNAL OPHTHALMOPLEGIA; FATIGUE; FRIEDREICH ATAXIA; GASTROINTESTINAL MOTILITY DISORDER; GENE MUTATION; GENETIC DISORDER; HEARING IMPAIRMENT; HUMAN; INFANCY; KEARNS SAYRE SYNDROME; KIDNEY CALCIFICATION; KIDNEY DISEASE; KIDNEY TUBULE DISORDER; LIPOMATOSIS; LIVER DISEASE; MALABSORPTION; MICROCEPHALY; MIGRAINE; MUSCLE HYPOTONIA; MYOCLONUS; MYOCLONUS EPILEPSY; MYOPATHY; NEUROPATHY; OPTIC NERVE DISEASE; PALLOR; PANCREAS EXOCRINE INSUFFICIENCY; PANCYTOPENIA; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PTOSIS; RETINITIS; REVIEW; SEIZURE; SIDEROBLASTIC ANEMIA; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; WOLFRAM SYNDROME; CLASSIFICATION; COMPLICATION; DIABETES INSIPIDUS; GENETICS; HEREDITARY OPTIC ATROPHY; MITOCHONDRIAL DISEASES; MUTATION; PERCEPTION DEAFNESS;

DIABETES INSIPIDUS; DIABETES MELLITUS; DIAGNOSIS, DIFFERENTIAL; DNA COPY NUMBER VARIATIONS; DNA, MITOCHONDRIAL; HEARING LOSS, SENSORINEURAL; HUMANS; KEARNS-SAYRE SYNDROME; MITOCHONDRIAL DISEASES; MUTATION; OPTIC ATROPHIES, HEREDITARY; RNA, TRANSFER, LEU;

EID: 84921503893     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12223     Document Type: Review

References (35)

1. Cree LM, Samuels DC, Chinnery PF. The inheritance of pathogenic mitochondrial DNA mutations. Biochim Biophys Acta 2009: 1792: 1097-1102.
2. Schaefer AM, Walker M, Turnbull DM, Taylor RW. Endocrine disorders in mitochondrial disease. Mol Cell Endocrinol 2013: 379: 2-11.
3. Kerr DS. Treatment of mitochondrial electron transport chain disorders: a review of clinical trials over the past decade. Mol Genet Metab 2010: 99: 246-255.
4. Lindroos MM, Majamaa K, Tura A et al. m.3243A>G mutation in mitochondrial DNA leads to decreased insulin sensitivity in skeletal muscle and to progressive beta-cell dysfunction. Diabetes 2009: 58: 543-549.
5. Velho G, Byrne MM, Clement K et al. Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu(UUR) gene mutation. Diabetes 1996: 45: 478-487.
6. El-Hattab AW, Emrick LT, Hsu JW et al. Glucose metabolism derangements in adults with the MELAS m.3243A>G mutation. Mitochondrion 2014 S1567-7249(14)00099-3.
7. Blake R, Trounce IA. Mitochondrial dysfunction and complications associated with diabetes. Biochim Biophys Acta 2014: 1840: 1404-1412.
8. Tang X, Luo YX, Chen HZ, Liu DP. Mitochondria, endothelial cell function, and vascular diseases. Front Physiol 2014: 5: 175.
9. Martin SD, McGee SL. The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes. Biochim Biophys Acta 2014: 1840: 1303-1312.
10. Uchigata Y, Okada T, Gong JS, Yamada Y, Iwamoto Y, Tanaka M. A mitochondrial genotype associated with the development of autoimmune-related type 1 diabetes. Diabetes Care 2002: 25: 2106.
11. Chen J, Gusdon AM, Mathews CE. Role of genetics in resistance to type 1 diabetes. Diabetes Metab Res Rev 2011: 27: 849-853.
12. Karicheva OZ, Kolesnikova OA, Schirtz T et al. Correction of the consequences of mitochondrial 3243A>G mutation in the MT-TL1 gene causing the MELAS syndrome by tRNA import into mitochondria. Nucleic Acids Res 2011: 39: 8173-8186.
13. Mancuso M, Orsucci D, Angelini C et al. The m.3243A > G mitochondrial DNA mutation and related phenotypes. A matter of gender? J Neurol 2014: 261: 504-510.
14. Koga Y, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T. MELAS and L-arginine therapy: pathophysiology of stroke-like episodes. Ann N Y Acad Sci 2010: 1201: 104-110.
15. Rahman S, Poulton J, Marchington D, Suomalainen A. Decrease of 3243 A→G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. Am J Hum Genet 2001: 68: 238-240.
16. McConnell JM, Petrie L. Mitochondrial DNA turnover occurs during preimplantation development and can be modulated by environmental factors. Reprod Biomed Online 2004: 9: 418-424.
17. Whittaker RG, Blackwood JK, Alston CL et al. Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A > G mtDNA mutation. Neurology 2009: 72: 568-569.
18. Whittaker RG, Schaefer AM, McFarland R, Taylor RW, Walker M, Turnbull DM. Prevalence and progression of diabetes in mitochondrial disease. Diabetologia 2007: 50: 2085-2089.
19. Laloi-Michelin M, Meas T, Ambonville C et al. The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. J Clin Endocrinol Metab 2009: 94: 3025-3030.
20. DiMauro S, Hirano M. Mitochondrial DNA deletion syndromes. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, Smith RJH, Stephens K, eds. GeneReviews(R). Seattle, WA: University of Washington, Seattle, 1993.
21. Williams TB, Daniels M, Puthenveetil G, Chang R, Wang RY, Abdenur JE. Pearson syndrome: unique endocrine manifestations including neonatal diabetes and adrenal insufficiency. Molecular genetics and metabolism 2012: 106: 104-107.
22. Whittaker RG, Schaefer AM, McFarland R, Taylor RW, Walker M, Turnbull DM. Diabetes and deafness: is it sufficient to screen for the mitochondrial 3243A>G mutation alone? Diabetes Care 2007: 30: 2238-2239.
23. Di Donato S. Multisystem manifestations of mitochondrial disorders. J Neurol 2009: 256: 693-710.
24. Chinnery PF, Hudson G. Mitochondrial genetics. Br Med Bull 2013: 106: 135-159.
25. El-Hattab AW, Scaglia F. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics 2013: 10: 186-198.
26. Rubio-Cabezas OHA, Njølstad PR, Mlynarski W et al. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatric Diabetes 2014: 15 (Supplement 20): 47-64.
27. Rigoli L, Di Bella C. Wolfram syndrome 1 and Wolfram syndrome 2. Curr Opin Pediatr 2012: 24: 512-517.
28. Cnop M, Mulder H, Igoillo-Esteve M. Diabetes in Friedreich ataxia. J Neurochem 2013: 126 (Suppl 1): 94-102.
29. Guillausseau PJ, Dubois-Laforgue D, Massin P et al. Heterogeneity of diabetes phenotype in patients with 3243 bp mutation of mitochondrial DNA (Maternally Inherited Diabetes and Deafness or MIDD). Diabetes Metab 2004: 30: 181-186.
30. Kobayashi T, Nakanishi K, Nakase H et al. In situ characterization of islets in diabetes with a mitochondrial DNA mutation at nucleotide position 3243. Diabetes 1997: 46: 1567-1571.
31. Oka Y, Katagiri H, Yazaki Y, Murase T, Kobayashi T. Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-depend-ent diabetics. Lancet 1993: 342: 527-528.
32. Suzuki S. Diabetes mellitus with mitochondrial gene mutations in Japan. Ann N Y Acad Sci 2004: 1011: 185-192.
33. Lee WJ, Lee HW, Palmer JP et al. Islet cell autoimmunity and mitochondrial DNA mutation in Korean subjects with typical and atypical Type I diabetes. Diabetologia 2001: 44: 2187-2191.
34. Piel S, Ehinger JK, Elmer E, Hansson MJ. Metformin induces lactate production in peripheral blood mononuclear cells and platelets through specific mitochondrial complex I inhibition. Acta Physiol (Oxf) 2014. doi: 10.1111/apha.12311. [Epub ahead of print]
35. Malfatti E, Laforet P, Jardel C et al. High risk of severe cardiac adverse events in patients with mitochondrial m.3243A>G mutation. Neurology 2013: 80: 100-105.